Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

MALAYSIA: Malaysian Mosque Is also a Methadone Clinic


New York Times (03.28.12) - Tuesday, April 03, 2012

In 2010, Malaysia's Ar-Rahman became the world's first mosque to house a methadone program, according to the World Health Organization.

With 170,000 injecting drug users, and drug injection the leading cause for HIV transmission, Malaysia's new HIV infections reached 7,000 in 2002. After the first patient- funded methadone treatment program launched at the University of Malaya, new infections dropped to approximately 6,100. That success spurred introduction of the first national, government-funded program in 2005.

Despite expansion of those government programs, a dearth of clinics with adequate resources left many untreated, said Dr. Rusdi Abdul Rashid, chief coordinator of the University of Malaya's Center of Addiction Sciences, which runs the Ar- Rahman program.

To overcome the opposition of mosque authorities and the government departments that must sanction activities in Malaysia's mosques, doctors argued that methadone was permitted by Islam because it is medicinal and does not produce feelings of euphoria.

According to Rusdi, the Ar-Rahman program has 50 patients, ages 18 to 60, who pay 15 ringgit (US $4.90) to participate. For the first eight weeks, as part of their "spiritual enhancement," patients pray first, then take the methadone under a pharmacist's supervision. Months later, and after at least two consecutive negative drug tests, patients may take home up to three doses.

Methadone and needle-exchange programs halved Malaysia's new HIV cases to 3,080 by 2009, its lowest rate since 1993. However, new infections rose to 3,652 in 2010, as sex eclipsed injection drug use in causing HIV transmissions.

"We are currently campaigning to other religious authorities and leaders in the country to adopt this program," said Mohammad Zaman Khan, the Malaysian AIDS Council's president.


Copyright © 2012 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

Information in this article was accurate in April 3, 2012. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.